BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31557600)

  • 1. Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients.
    Real SAS; Parveen F; Rehman AU; Shaik R; Deo SVS; Husain SA
    Mutat Res; 2019 Nov; 816-818():111677. PubMed ID: 31557600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Promoter Methylation of YAP Gene and its Subsequent Downregulation in Indian Breast Cancer Patients.
    Real SAS; Parveen F; Rehman AU; Khan MA; Deo SVS; Shukla NK; Husain SA
    BMC Cancer; 2018 Jul; 18(1):711. PubMed ID: 29970036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.
    Cho YG; Chang X; Park IS; Yamashita K; Shao C; Ha PK; Pai SI; Sidransky D; Kim MS
    Int J Oncol; 2011 Aug; 39(2):337-44. PubMed ID: 21617854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of MGMT in correlation with aberrant DNA methylation in esophageal cancer patients from North India.
    Rehman AU; Saikia S; Iqbal MA; Ahmad I; Sadaf ; Anees A; Aravinda PS; Mishra PK; Hedau S; Saluja SS; Medhi S; Husain SA
    Tumour Biol; 2017 Jun; 39(6):1010428317705770. PubMed ID: 28621225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on promoter methylation of PTEN in sporadic breast cancer patients from North India.
    Siddiqui S; Akhter N; Deo SV; Shukla NK; Husain SA
    Breast Cancer; 2016 Nov; 23(6):922-931. PubMed ID: 26754093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
    Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
    Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN Genetic and Epigenetic Alterations Define Distinct Subgroups in North Indian Breast Cancer Patients.
    Kazim Z; Wahabi K; Perwez A; Lal P; Rizvi MA
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):269-276. PubMed ID: 30678449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
    Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.
    Lei C; Lv S; Wang H; Liu C; Zhai Q; Wang S; Cai G; Lu D; Sun Z; Wei Q
    DNA Cell Biol; 2018 Aug; 37(8):659-669. PubMed ID: 29902078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
    Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
    Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the DNA methylation and gene expression of IGFBP5 in breast cancer.
    Karabulut S; Kaya Z; Amuran GG; Peker I; Özmen T; Gūllūoḡlu BM; Kaya H; Erzik C; Ōzer A; Akkiprik M
    Breast Dis; 2016; 36(4):123-131. PubMed ID: 27612043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study.
    Venkatesh T; Shetty A; Chakraborti S; Suresh PS
    J Cell Physiol; 2019 Feb; 234(2):1071-1079. PubMed ID: 30189107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma.
    Woo HY; DO SI; Kim SH; Song SY; Kim HS
    Anticancer Res; 2019 Oct; 39(10):5361-5367. PubMed ID: 31570430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].
    Veeck J; Breuer E; Rose M; Chorovicer M; Naami A; Bektas N; Alkaya S; von Serényi S; Horn F; Hartmann A; Knüchel R; Dahl E
    Pathologe; 2008 Nov; 29 Suppl 2():338-46. PubMed ID: 18810445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
    Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
    Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
    Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
    Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) Expression Contributes to Lymph Node Metastasis of Breast Invasive Micropapillary Carcinoma.
    Wang XX; Liu BB; Wu X; Su D; Zhu Z; Fu L
    Pathol Oncol Res; 2015 Sep; 21(4):1021-6. PubMed ID: 25813822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.